GENOMENEXT

genomenext-logo

GenomeNext delivers an automated genomic analysis solution that provides researchers and clinicians with a real-time, secure and regulatory compliant environment to analyze genomic data. The GenomeNext analysis pipeline is the first comprehensive solution that can deliver accurate, reproducible and determinate genomic analysis results, from FASTQ to VCF to annotation in under 3 hours for whole genomes, under 1 hour per exome and 30 minutes per panel. GenomeNext delivers an automated genomic a... nalysis solution that provides researchers and clinicians with a real-time, secure and regulatory compliant environment to analyze genomic data. The GenomeNext analysis pipeline is the first comprehensive solution that can deliver accurate, reproducible and determinate genomic analysis results, from FASTQ to VCF to annotation in under 2 hours for whole genomes, under 1 hour per exome and 30 minutes per panel. Our proprietary algorithm powers a streamlined analysis platform delivering deterministic analyses to ensure your results are accurate and reproducible the first time and every time. Our analysis pipeline follows the commonly accepted best practices for both single sample and multisample variant discovery by performing alignment, deduplication, local realignment around indels, base quality score recalibration, variant calling and genotyping. Each step of the GenomeNext analysis pipeline has been carefully architected to rapidly align raw sequence reads to a reference genome, refine this alignment in areas where it is known that aligners can have difficulties, clean up lab prep and sequencer-related artifacts, and perform discovery of variants and genotypes with a high degree of confidence. GenomeNext automated analysis platform features: -Run exomes, targeted panels, and whole genomes -Run multiple samples in one analysis request -Analysis results in under 2 hours -100% Reproducible and Deterministic Results -Immediate download of VCF and Annotation files -Visualization of analyzed data -Cost-effective solution for clinical and research needs -Regulatory compliant platform -Enables population scale genomics -Secure storage of large genomic data -Secure platform that can be accessed from anywhere in the world -Reduce computational bottleneck -Collaboration platform for teams -Unlimited user accounts with access control features.

#SimilarOrganizations #People #Financial #Website #More

GENOMENEXT

Social Links:

Industry:
Biotechnology Genetics

Founded:
2014-03-15

Address:
Columbus, Ohio, United States

Country:
United States

Website Url:
http://www.genomenext.com

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
1.2 M USD

Technology used in webpage:
Apache YouTube ASP.NET IIS DigiCert SSL ASP.NET 4.0 Amazon SSL IIS 8 Digital Ocean ASP.NET MVC


Similar Organizations

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

Current Employees Featured

peter-white_image

Peter White
Peter White Co-Founder and Chief Scientific Advisor @ GenomeNext
Co-Founder and Chief Scientific Advisor
2014-03-01

Founder


christopher-s-drescher_image

Christopher S. Drescher

james-hirmas_image

James Hirmas

peter-white_image

Peter White

Investors List

hydra-capital_image

Hydra Capital

Hydra Capital investment in Seed Round - GenomeNext

Official Site Inspections

http://www.genomenext.com

  • Host name: 164.90.244.158
  • IP address: 164.90.244.158
  • Location: New York United States
  • Latitude: 40.7157
  • Longitude: -74
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 10013

Loading ...

More informations about "GenomeNext"

GenomeNext 2025 Company Profile: Valuation, Funding

GenomeNext General Information Description. Developer of an automated genomic analysis platform designed to streamline genomic analysis. The company's automated genomic …See details»

GenomeNext LLC Company Profile | Columbus, OH - Dun

Find company research, competitor information, contact details & financial data for GenomeNext LLC of Columbus, OH. Get the latest business insights from Dun & Bradstreet.See details»

GenomeNext - Intelligent Translational Bioinformatics

GenomeNext offers the only pipeline used for clinical application and discovery of novel variants that has been peer-reviewed and published. Genome Biology has validated our bioinformatics …See details»

GenomeNext LLC - Company Profile and News - Bloomberg Markets

Company profile page for GenomeNext LLC including stock price, company news, executives, board members, and contact informationSee details»

GenomeNext - The Org

GenomeNext delivers an automated genomic analysis solution that provides researchers and clinicians with a real-timeSee details»

GenomeNext - Products, Competitors, Financials, Employees, …

GenomeNext is a genomic informatics company dedicated to accelerating the promise and capability of predictive medicine and scientific discovery. Use the CB Insights Platform to …See details»

GenomeNext LLC Company Profile, Financial and Strategic

GenomeNext LLC, a bioinformatics company, provides genomic analysis services. The company focuses on automated informatics and data management solutions to enhance analysis …See details»

GenomeNext LLC Overview | SignalHire Company Profile

GenomeNext LLC is a private company that has been in the industry for 9 years. The company currently specializes in the Biotechnology area. The position of the CEO is occupied by James …See details»

GenomeNext | VentureRadar

GenomeNext VentureRadar profile. Find out more about GenomeNext including the VentureRadar Innovation and Growth scores, Similar Companies and more.See details»

GenomeNext LLC - Drug pipelines, Patents, Clinical trials - Synapse

Explore GenomeNext LLC with its drug pipeline, therapeutic area, technology platform, .See details»

GenomeNext - Contacts, Employees, Board Members, Advisors

Organization. GenomeNext . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. GenomeNext has …See details»

GenomeNext - 2025 Funding Rounds & List of Investors - Tracxn

Apr 20, 2025 GenomeNext's largest funding round was a Seed round held on Feb 26, 2016 for $1.2M. View all funding & investor details of GenomeNext. Our Lite Plan Awaits you - Its Free! …See details»

EIN 46-4808018 - Genomenext Llc, Columbus, Ohio - EIN TaxId

Genomenext Llc is a corporation in Columbus, Ohio. The employer identification number (EIN) for Genomenext Llc is 464808018. EIN for organizations is sometimes also referred to as …See details»

GenomeNext Raises $1.2M in Seed Funding - FinSMEs

Feb 24, 2016 GenomeNext, LLC, a Columbus, OH-based developer of genomic data management and integrated analysis solutions, raised $1.2m in seed funding. The round was …See details»

GenomeNext - Tech Company Profile - Gaebler.com Venture …

Headquartered in Columbus, GenomeNext has funding from Hydra Capital and private investors. Company Overview. Company Name. GenomeNext. Company Status. Private & Independent. …See details»

GenomeNext Is Building a Startup on Know-how and Relationships

Sep 22, 2015 James Hirmas, founder and CEO of GenomeNext, has been engaged with Amazon Web Services (AWS) and cloud computing from the formative days. He’s also worked …See details»

GenomeNext - Funding, Financials, Valuation & Investors

GenomeNext delivers an automated genomic analysis solution that provides researchers and clinicians with a real-timeSee details»

GenomeNext DevOps Process - Effectual

We worked with GenomeNext to design efficient development and agile management process, setup internal DevOps software and AWS infrastructure components, mapped processes to …See details»

GenomeNet Database Resources

GenomeNet is a Japanese network of database and computational services for genome research and related research areas in biomedical sciences.See details»

GenomeNext Raises $1.2M in Seed Financing | GenomeWeb

Feb 24, 2016 More recently, GenomeNext benchmarked a timeframe for the analysis of a massive quantity of genomic data demonstrating population-scale capability. The firm analyzed the whole genomes and exomes of 2,504 individuals sampled across 26 different populations in one week, processing 1,000 samples per day, and generating close to 100 terabytes of …See details»

linkstock.net © 2022. All rights reserved